Carna Biosciences Inc
TSE:4572
Intrinsic Value
Carna Biosciences, Inc. engages in the drug discovery business. [ Read More ]
The intrinsic value of one Carna Biosciences Inc stock under the Base Case scenario is 378.31 JPY. Compared to the current market price of 468 JPY, Carna Biosciences Inc is Overvalued by 19%.
Valuation Backtest
Carna Biosciences Inc
Run backtest to discover the historical profit from buying and selling Carna Biosciences Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Carna Biosciences Inc's business.
What risks and challenges
does Carna Biosciences Inc face in the near future?
Summarize the latest earnings report
of Carna Biosciences Inc.
Provide P/E
for Carna Biosciences Inc and its competitors.
Balance Sheet Decomposition
Carna Biosciences Inc
Current Assets | 4.2B |
Cash & Short-Term Investments | 2.9B |
Receivables | 788.2m |
Other Current Assets | 514.2m |
Non-Current Assets | 158.4m |
PP&E | 105.5m |
Intangibles | 1.1m |
Other Non-Current Assets | 51.8m |
Current Liabilities | 375.9m |
Accounts Payable | 1.2m |
Other Current Liabilities | 374.7m |
Non-Current Liabilities | 96.4m |
Long-Term Debt | 56.4m |
Other Non-Current Liabilities | 40m |
Earnings Waterfall
Carna Biosciences Inc
Revenue
|
1.6B
JPY
|
Cost of Revenue
|
-175.3m
JPY
|
Gross Profit
|
1.5B
JPY
|
Operating Expenses
|
-2.6B
JPY
|
Operating Income
|
-1.1B
JPY
|
Other Expenses
|
-35.9m
JPY
|
Net Income
|
-1.2B
JPY
|
Free Cash Flow Analysis
Carna Biosciences Inc
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Carna Biosciences Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Carna Biosciences Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Carna Biosciences Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Carna Biosciences Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Carna Biosciences Inc
Shareholder Return
Price
Carna Biosciences Inc
Average Annual Return | -0.97% |
Standard Deviation of Annual Returns | 67.57% |
Max Drawdown | -87% |
Market Capitalization | 8B JPY |
Shares Outstanding | 17 144 800 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Carna Biosciences, Inc. engages in the drug discovery business. The company is headquartered in Kobe, Hyogo-Ken and currently employs 64 full-time employees. The company went IPO on 2008-03-25. The firm operates in two business segments. The Drug Development Support segment is engaged in sales of protein kinase, development of assay, as well as provision of profiling and screening service. The Drug Development segment is engaged in the research and development of kinase inhibitors and other drugs.
Contact
IPO
Employees
Officers
The intrinsic value of one Carna Biosciences Inc stock under the Base Case scenario is 378.31 JPY.
Compared to the current market price of 468 JPY, Carna Biosciences Inc is Overvalued by 19%.